Pfizer

NALBUPHINE HCL

Manufacturer:

Pfizer

Nalbuphine Hcl HCPCS:

J2300

HCPCS Code Descriptor:

Injection, nalbuphine hydrochloride, per 10 mg

Category:

J Code

Nalbuphine Hcl NDCs:

00409-1464-01, 00409-1463-01, 00409-1463-49, 00409-1467-01, 00409-1465-01

Primary Type:

Anti-Addiction

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00409-1464-01, 00409-1463-01, 00409-1463-49, 00409-1467-01, 00409-1465-01

About Nalbuphine Hcl:

NALBUPHINE HCL is an Anti-Addiction drug manufactured by Pfizer and administered via the Injection route of administration. The J Code: J2300 is aligned to the drug NALBUPHINE HCL.

ACCESS PRICING AND MORE BY REGISTERING

J2300 Added Date:

January 1, 1996

J2300 Effective Date:

January 1, 1997

J2300 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Nalbuphine Hcl billing and coding information.
Our team did not identify a source for Nalbuphine Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
NALBUPHINE HCL prescribing information can be found at the link below:
Information regarding NALBUPHINE HCL’s side effects can be found at MedlinePlus